Geldanamycin Analogue in Treating Patients With Advanced Cancer
NCT00003969
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
tanespimycin
Sponsor
Cancer Research UK